HST Global Inc. ROE

ROE of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including ROE growth rates and interactive chart. ROE is expressed as a percentage and can be calculated for any company if net income and equity are both positive numbers. Net income is calculated before dividends paid to common shareholders and after dividends to preferred shareholders and interest to lenders. A company with average equity of $10 million and earnings of $2 milion will have a ROE of 20%.

Highlights and Quick Summary

  • Annual ROE for 2019 was -25.29% (a -565.75% decrease from previous year)
  • Annual ROE for 2018 was 5.43% (a 2.26% increase from previous year)
  • Annual ROE for 2017 was 5.31% (a -9.69% decrease from previous year)
  • Twelve month ROE ending June 29, 2020 was -83.4% (a 229.64% increase compared to previous quarter)
  • Twelve month trailing ROE increased by 237.38% year-over-year
Trailing ROE for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
-83.4% -25.3% -25.29% -24.72%
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical ROE of HST Global Inc.

Most recent ROEof HSTC including historical data for past 10 years.

Interactive Chart of ROE of HST Global Inc.

HST Global Inc. ROE for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2019 -25.29%
2018 5.43%
2017 5.31%
2016 5.88%
2015 7.1%
2014 7.2%
2013 8.1%
2012 17.96%
2011 28.82%
2010 53.44%
2009 0.0%

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.